Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Larotinib mesylate hydrate | 2097129-93-4 | C26H36ClFN4O11S2 | 50 MG
SDP

Catalog No. 5000373134
Encompass_Preferred

Larotinib mesylate hydrate is a potent, broad-spectrum, and orally active tyrosine kinase inhibitor (TKI) with EGFR as its primary target, demonstrating an IC50 of 0.6 nM. This compound is intended for research use only.

  • Potent broad-spectrum and orally active tyrosine kinase inhibitor
  • Primary target is EGFR with an IC50 of 0.6 nM
  • Purity of 98.66%
  • Appears as a white to off-white solid
  • Molecular weight of 699.17
  • Soluble in DMSO at 25 mg/mL (35.76 mM)
  • Stock solution can be stored at -80°C for 6 months or -20°C for 1 month (sealed, away from moisture)

Catalog No. 50-003-73134 Supplier Medchemexpress LLC Supplier No. HY153110A50MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Larotinib mesylate hydrate is a potent, broad-spectrum, and orally active tyrosine kinase inhibitor (TKI) with EGFR as its primary target, demonstrating an IC50 of 0.6 nM. This compound is intended for research use only.

  • Potent broad-spectrum and orally active tyrosine kinase inhibitor
  • Primary target is EGFR with an IC50 of 0.6 nM
  • Purity of 98.66%
  • Appears as a white to off-white solid
  • Molecular weight of 699.17
  • Soluble in DMSO at 25 mg/mL (35.76 mM)
  • Stock solution can be stored at -80°C for 6 months or -20°C for 1 month (sealed, away from moisture)

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.